Significance of fluoroquinolone-resistant Escherichia coli in urinary tract infections

Japanese Journal of Infectious Diseases

Volumn 61, Issue 3, 2008, Pages 226-228

  Shigemura, Katsumi ^a   Arakawa, Soichi ^a   Miura, Tetsuya ^a   Nakano, Yuzo ^a   Tanaka, Kazushi ^a   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFMETAZOLE; CEFTAZIDIME; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; HABEKACIN; IMIPENEM; MINOCYCLINE; OFLOXACIN; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; ESCHERICHIA COLI; FLUOROQUINOLONE RESISTANT ESCHERICHIA COLI; HUMAN; INCIDENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STRAIN DIFFERENCE; TREND STUDY; URINARY TRACT INFECTION; URINE CULTURE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; HOSPITALS, UNIVERSITY; HUMANS; JAPAN; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTIONS;

EID: 45849098768     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Wagenlehner, F.M. and Naber, K.G. (2004): New drugs for Grampositive uropathogens. Int. J. Antimicrob. Agents, 24, S39-43.
2. Linuma, Y. (2007): Infection control strategies for antimicrobial-resistance. Nippon Rinsho, 65, 175-184 (in Japanese).
3. Mikamo, H., Tanaka, K., Watanabe, K., et al. (2006): Surveillance on Pseudomonas aeruginosa isolated in Gifu Prefecture (2004). Jpn. J. Antibiot., 59, 355-363 (in Japanese).
4. Kim, B.N., Choi, S.I. and Ryoo, N.H. (2006): Three-year follow-up of an outbreak of Serratia marcescens bacteriuria in a neurosurgical intensive care unit. J. Korean Med. Sci., 21, 973-978.
5. Schaberg, D.R., Alford, R.H., Anderson, R., et al. (1976): An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread. J. Infect. Dis., 134, 181-188.
6. Gold, U.S. (2001): Vancomycin-resistant enterococci: mechanisms and clinical observations. Clin. Infect. Dis., 33, 210-219.
7. Taneja, N., Rani, P., Emmanuel, R., et al. (2004): Significance of vancomycin resistant enterococci from urinary specimens at a tertiary care centre in northern India. Indian J. Med. Res., 119, 72-74.
8. Bhattacharya, S. (2006): ESBL-from petri dish to the patient. Indian J. Med. Microbiol., 24, 20-24.
9. Akram, M., Shahid, M. and Khan, A.U. (2007): Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital, Aligarh, India. Ann. Clin. Microbiol. Antimicrob., 6, 4.
10. Kader, A.A. and Angamuthu, K. (2005): Extended-spectrum betalactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in eastern province, Saudi Arabia. Saudi Med. J., 26, 956-959.
11. Honda, M., Seki, H., Aso, K., et al. (2005): A bacteriological study of multiple-drug-resistant Pseudomonas aeruginosa isolates derived from 2 patients. J. UOEH, 27, 209-217 (in Japanese).
12. Weigel, L.M., Donlan, R.M., Shin D.H., et al. (2007): High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob. Agents Chemother., 51, 231-238.
13. Moreno, E., Prats, G., Sabaté, M., et al. (2006): Quinolone, tluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coil. J. Antimicrob. Chemother., 57, 204-211.
14. Eom, J.S. Hwang, B.Y. and Sohn, J.W. (2002): Clinical and molecular epidemiology of quinolone-resistant Escherichia coli isolated from urinary tract infection Microb. Drug Resist., 8, 227-234.
15. Killgore, K.M., March, K.L. and Guglielmo, B.J. (2004): Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann. Pharmacother., 38, 1148-1152.